GlobalDeal

Quantum Genomics

Biopharmaceutical · Paris, France

quantum-genomics.com

About Quantum Genomics

Quantum Genomics is a biopharmaceutical company focused on the development of innovative therapies for the treatment of cardiovascular diseases. The company specializes in the research and development of new drugs that target the renin-angiotensin system, which plays a crucial role in blood pressure regulation. Quantum Genomics aims to address unmet medical needs in hypertension and heart failure through its proprietary drug candidates. The company is committed to advancing its clinical programs and collaborating with healthcare professionals to bring effective treatments to market. With a strong emphasis on scientific research and clinical trials, Quantum Genomics is positioned to make significant contributions to the field of cardiovascular medicine.

Company facts

Industry
Biopharmaceutical
Sub-industries
Pharmaceuticals, Cardiovascular, Clinical Research, Drug Development, Healthcare
Location
Paris, France
Employees
1–10
Revenue (USD)
<1M

Products and services

Open Quantum Genomics in GlobalDeal Is this your company? Update the details for free

More Biopharmaceutical companies in France